Join to view full profile
8700 Beverly Blvd.AC1070Los Angeles, CA 90095
Phone+1 310-423-1160
Fax+1 310-659-8045
Dr. Paquette is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1990- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1984 - 1987
Ohio State University College of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1987 - 2028
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Fludarabine and Total Body Irradiation 800 or 1125 cGy for Allogeneic Stem Cell Transplant Using Graft-Versus-Host Disease Prophylaxis with Post-Transplant Cyclophosph...Ronald Paquette, Haein Kim, Vinicius F Calsavara, Noah Merin, John Chute
Transplantation and Cellular Therapy. 2026-09-07 - 1 citationsPre-vaccine immune profiling in cancer patients identifies correlates of COVID-19 vaccine responses.Maryam Kazerani, Simeon Mahov, Joslyn Foley, Noah M Merin, So Yung Choi
Human Vaccines & Immunotherapeutics. 2025-12-01 - 3 citationsLow booster uptake in cancer patients despite health benefits.Jane C Figueiredo, Julia Levy, So Yung Choi, Alexander M Xu, Noah M Merin
Iscience. 2024-09-20
Press Mentions
Youngest Cedars-Sinai Stem Cell Donor Helps Doctors Treat Dad’s LeukemiaSeptember 16th, 2025- Cedars-Sinai Again Earns Top Ranking for Blood and Marrow TransplantsFebruary 6th, 2025
- Cedars-Sinai’s Stem Cell and Bone Marrow Transplant Program Recognized with Two Major Hallmarks of QualityJanuary 18th, 2023
Grant Support
- Phase I Study Of Recombinant Human Hemoglobin (Rhb1.1) In Patients W/AnemiaNational Center For Research Resources1999–2001
- Phase I/II Trial Of Recombinant Methionyl Human Stem Cell FactorNational Center For Research Resources1995–1999
- Phase I Study Of Recombinant Human Hemoglobin (Rhb1.1) In Patients W/Anemia ASSNational Center For Research Resources1998
- Myeloid Specific Regulation Of IGG FC Receptor Type INational Heart, Lung, And Blood Institute1994–1997
- Myeloid-Specific Regulation Of IGG FC Receptor Type INational Heart, Lung, And Blood Institute1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
